Citi

A pair of seasoned green bond issuers brought deals in the format this week — but each opted to print in a currency in which it had not sold green bonds before.

Banks have been hiring staff to help financial sponsors hunt jumbo take-private deals as opportunities dry up elsewhere, writes David Rothnie.

Goldman’s Furtado heads to Citi — HNA chairman dies on business trip — Veteran loans banker Pemberton passes away — Everbright nabs structured finance boss — Chaudhry leaves Deutsche to study

More Chinese technology start-ups have come out with their IPO plans, as Pinduoduo, Aurora Mobile and Opera file their US debuts.

Hong Kong was inundated with IPO filings this week as banks sought to give themselves enough runway to launch deals before the end of the year.

The Hong Kong Stock Exchange’s revolutionary change to its listing regime for biotechnology companies is starting to pay off, as the pipeline of pre-revenue firms looking to go public builds. But there are numerous challenges ahead, not least in understanding the sector and the risks involved. Jonathan Breen reports.

Inke priced its Hong Kong IPO at the low end of expectations on Thursday to raise HK$1.2bn ($152.9m), amid investor jitters about a China-US trade war.

Asian Development Bank picked up €600m and was able to tighten pricing as it sold a green bond in euros for the first time.

Hong Kong start-up Welab Holdings has filed a listing application with Morgan Stanley as lead left underwriter and sponsor alongside JP Morgan.

Bio-technology firms AOBiome Therapeutics and Stealth Biotherapeutics Corp are seeking the greenlight to float in Hong Kong, adding to a fast-growing pipeline from the sector.

A pair of supranational issuers are this week bringing new currencies to their green funding offerings.

Opera’s planned $115m Nasdaq IPO now has a cryptocurrency angle after Bitmain, a Chinese bitcoin miner, joined the deal as an anchor investor.